BRAINBiotech

BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology

Newly patented CRISPR nuclease exhibits high activity in various prokaryotic and eukaryotic organismsPatent now opens up significant potential for further commercial use through licensing BRAIN Biotech offers its technology for strain optimization in customers' production strains. 23 March 2026 -- Zwingenberg, Germany -- BRAIN Biotech, a leading provider of specialist enzymes and innovative biological solutions...

BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure

Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds Aurase shows dual action on chronic wound debridement and healing SolasCure preparing fund raising for clinical phase 2b/3 Sequential growth forecasted in the next quarters for BRAINBiocatalysts. 25 February 2026 -- Zwingenberg, Germany -- BRAIN Biotech AG, a leading provider...
Darmstädter Straße 34 – 36 64673 Zwingenberg Deutschland

+49 62 51 9331-0